Johnson & Johnson announced that the results of its clinical trial found that its single-dose coronavirus vaccine was 66% effective in protecting against COVID-19. The company said that the vaccine’s effectiveness varied by region and was less effective in countries that have been dealing with new, more transmissible strains of the virus.